An Open-Label, Extension Study to Assess the Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children Who Completed the OTR3001 Study. Protocol No. OTR3002.

  • Lommel, Karen (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/19/126/30/12